NCT03556228 2025-12-11VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaVM Oncology, LLCPhase 1/2 Recruiting242 enrolled
NCT01976741 2021-05-06Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)BayerPhase 1 Completed168 enrolled 59 charts
NCT00667485 2014-01-17Rapamycin Plus Bevacizumab in Advanced CancersUniversity of ChicagoPhase 1 Completed28 enrolled